Verma, B.; Chen, G.Z.; Waller, E.K.; Patel, M.; Anderson, A.; Goodwin, N.; Wesa, A.; Teng, Y.; Saba, N.F.
Feasibility Assessment of Autologous Human Immune System (HIS) ImmunoGraft Platform Development Using Autologous Mobilized Peripheral Blood (MPB) CD34 Cells Derived from Adult HNSCC Patient. Int. J. Mol. Sci. 2025, 26, 5269.
https://doi.org/10.3390/ijms26115269
AMA Style
Verma B, Chen GZ, Waller EK, Patel M, Anderson A, Goodwin N, Wesa A, Teng Y, Saba NF.
Feasibility Assessment of Autologous Human Immune System (HIS) ImmunoGraft Platform Development Using Autologous Mobilized Peripheral Blood (MPB) CD34 Cells Derived from Adult HNSCC Patient. International Journal of Molecular Sciences. 2025; 26(11):5269.
https://doi.org/10.3390/ijms26115269
Chicago/Turabian Style
Verma, Bhavna, Georgia Zhuo Chen, Edmund K. Waller, Mihir Patel, Allyson Anderson, Neal Goodwin, Amy Wesa, Yong Teng, and Nabil F. Saba.
2025. "Feasibility Assessment of Autologous Human Immune System (HIS) ImmunoGraft Platform Development Using Autologous Mobilized Peripheral Blood (MPB) CD34 Cells Derived from Adult HNSCC Patient" International Journal of Molecular Sciences 26, no. 11: 5269.
https://doi.org/10.3390/ijms26115269
APA Style
Verma, B., Chen, G. Z., Waller, E. K., Patel, M., Anderson, A., Goodwin, N., Wesa, A., Teng, Y., & Saba, N. F.
(2025). Feasibility Assessment of Autologous Human Immune System (HIS) ImmunoGraft Platform Development Using Autologous Mobilized Peripheral Blood (MPB) CD34 Cells Derived from Adult HNSCC Patient. International Journal of Molecular Sciences, 26(11), 5269.
https://doi.org/10.3390/ijms26115269
